Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PLEASANTON, Calif., May 2, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the first quarter of 2013.
For the quarter ended March 30, 2013, Thoratec reported revenues of $117.7 million, a 7 percent decrease versus revenues of $126.8 million in the same period a year ago.
Help employers find you! Check out all the jobs and post your resume.
PLEASANTON, Calif., May 2, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the first quarter of 2013.
For the quarter ended March 30, 2013, Thoratec reported revenues of $117.7 million, a 7 percent decrease versus revenues of $126.8 million in the same period a year ago.
Help employers find you! Check out all the jobs and post your resume.
